Improving Anti-malarial Treatment Options in Guinea-Bissau - Part A

NCT01704508 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

346

Enrollment

OTHER

Sponsor class

Conditions

Malaria

Interventions

DRUG: Artemether-lumefantrine
DRUG: Dihydroartemisinin-piperaquine

Sponsor

Bandim Health Project

Collaborators

[object Object]